Welcome To The UCLA Dual Diagnosis Program
Treatment For Addiction And Co-Occurring Mental Health Conditions
Although addiction trends in the United States have changed over the years, addiction remains one of the most challenging issues facing America. In addition to addictions to illegal drugs like heroin, methamphetamine, and cocaine, an increasing number of individuals are developing addictions to prescription drugs (e.g., OxyContin and Xanax) as well as to relatively new "designer drugs" (e.g., bath salts, K2, spice), inhalants, and sleep aids. Behavioral addictions (also called process addictions) have become more prevalent as well with pathological gambling and sex addiction in the foreground. The National Institute on Drug Abuse reports that individuals who suffer from an addiction are twice as likely as their healthy counterparts to also suffer from another mental health condition as well.
For many years, the Resnick Neuropsychiatric Hospital at UCLA has consistently ranked as "Best in the West" for psychiatry as part of the US News and World Report rankings of top hospitals. As an extension of its reputation as a leader in treating psychiatric conditions, UCLA added the Dual Diagnosis Program to its treatment services in 2012. This program specializes in treating recovering addicts who have also been diagnosed with co-occurring depressive disorders, anxiety disorders, bipolar disorder, and ADHD, in an intensive outpatient environment. The program's clinicians are experts in the field of addiction medicine with extensive experience treating multiple mental health conditions simultaneously. To inquire about the program or to schedule an appointment, please contact us.
Mark A. Frye, M.D.
Professor of Psychiatry
Director, The Integrated Mood Group Mayo Clinic
NEW--Podcast Preview available on the website, www.psychiatrygrandrounds.com
Coffee will be served in the auditorium foyer beginning at 10:45 AM. As always, free continuing educational credits are available for Grand Rounds; please be sure that you have filled out the forms to receive credit for your attendance.
For information on upcoming Semel Institute Grand Rounds please visit: www.psychiatrygrandrounds.com
David Miklowitz, professor of psychiatry and director of the Child and Adolescent Mood Disorders Program at the Semel Institute, was featured Aug. 22 in a Psychcentral.com article about helping a loved one with depression or bipolar disorder.